Fourth Circuit blocks West Virginia's 340B contract pharmacy law
Issue
The Fourth Circuit on March 31, 2026 upheld an injunction blocking West Virginia's SB 325, finding the 340B contract pharmacy law likely preempted. It is drugmakers' first federal appeals win on these laws and splits from the Fifth and Eighth Circuits, and hospital groups sought en banc review April 17.
It weakens Washington's SB 5981 and similar state laws.
Key points
- CA FQHCs hoping for state contract pharmacy protections such as AB 1460 (a bill that later died without a Senate vote) should assume legal uncertainty — the 4th Circuit's preemption framing will be cited in any PhRMA challenge to CA or WA state laws, and the 9th Circuit has not yet ruled on this question
- Watch for en banc ruling (petition filed April 17) before May 31 — denial would create binding 4th Circuit precedent and strengthen PhRMA's position in parallel lawsuits against WA SB 5981 and in anticipated CA challenges
Sources for this story
American Hospital AssociationPart of
- 340B drug pricing
State contract-pharmacy laws and the circuit split
Sources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
The newsletter is paused right now. Sign up and you will get it when it starts again.
Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
FQHC Talent. (2026, March 31). Fourth Circuit blocks West Virginia's 340B contract pharmacy law. Source: American Hospital Association. Retrieved November 22, 2026, from https://www.fqhctalent.com/intel/fourth-circuit-wv-sb325-340b-blocked-march-31-2026